The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

Now, new research suggests Eli Lilly’s weight loss drug Zepbound (tirzepetide) may also support those with obstructive sleep apnea by increasing airflow and improving sleep quality. Since sleep ...

A popular weight loss drug has become the first FDA-approved prescription medication to treat obstructive sleep apnea. Sleep ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea.

The U.S. Food and Drug Administration has approved Eli Lilly and Co. ’s obesity-treatment Zepbound as the first medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. Lilly ...

Wegovy was approved in the U.S. as a treatment for heart disease in March, while Zepbound is expected to be given the green light as a treatment for obstructive sleep apnea. Both drugs are sold in ...

Wegovy was approved in the US as a treatment for heart disease in March, while Zepbound is expected to be given the green light as a treatment for obstructive sleep apnea, as reported by Reuters.

Meanwhile, Zepbound has been shown to be a possible treatment for obstructive sleep apnea. Importantly, McGowan said weight loss isn't the only factor patients have to consider when picking a ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea. Health News // 16 ...

Zepbound is primarily targeted at adults living with obesity or overweight who have at least one weight-relatedcomorbidity, such as hypertension, dyslipidemia, obstructive sleep apnea (OSA), or ...

obstructive sleep apnea (OSA) or cardiovascular disease. The most commonly reported side effects among those taking both Zepbound and Wegovy were mild to moderate gastrointestinal symptoms ...